Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia

Annals of Hematology

Volumn 83, Issue 12, 2004, Pages 784-788

  Henzan, Hideho ^a   Yoshimoto, Goichi ^a   Okeda, Aki ^a   Nagasaki, Yoji ^a   Hirano, Gen ^a   Takase, Ken ^a   Tanimoto, Tetsuya ^a   Miyamoto, Toshihiro ^a   Fukuda, Takahiro ^a   Nagafuji, Koji ^a   Harada, Mine ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Blast crisis; Chronic myelogenous leukemia; EVI1; Myeloid natural killer cell lineage; Philadelphia chromosome

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; IMATINIB;

ADULT; ARTICLE; BLAST CELL CRISIS; BLAST TRANSFORMATION; BONE MARROW CELL; CASE REPORT; CELL CLONE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 7; CHRONIC MYELOID LEUKEMIA; DIARRHEA; EDEMA; FUSION GENE; GENE OVEREXPRESSION; HUMAN; IMMUNOPHENOTYPING; MALE; NATURAL KILLER CELL; NAUSEA; ONCOGENE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; RASH;

ADOLESCENT; ANTIGENS, CD; BLAST CRISIS; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; DNA-BINDING PROTEINS; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LYMPHOCYTE ACTIVATION; MALE; PHILADELPHIA CHROMOSOME; PROTO-ONCOGENES; TRANSCRIPTION FACTORS;

EID: 8444253663     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0932-1     Document Type: Article

References (23)

1. Calabretta B, Perrotti D (2004) The biology of CML blast crisis. Blood 103:4010-4022
2. Sun T, Susin M, Koduru P, Coffey EL Jr, Dittmar K, Weiss R, Goh J, Brody J (1991) Extramedullary blast crisis in chronic myelogenous leukemia. Demonstration of T-cell lineage and Philadelphia chromosome in a paraspinal tumor. Cancer 68:605-610
3. Dorfman DM, Longtine JA, Fox EA, Weinberg DS, Pinkus GS (1997) T-cell blast crisis in chronic myelogenous leukemia. Immunophenotypic and molecular biologic findings. Am J Clin Pathol 107:168-176
4. Okazuka K, Toba K, Kawai K, Nikkuni K, Tsuchiyama J, Momoi A, Kanazawa N, Nagai K, Suzuki N, Aizawa Y (2001) Extramedullary T lymphoid blast crisis representing an additional translocation, t(6;8)(q25;q22) in a patient with Philadelphia-positive chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res 25:1089-1094
5. Warzynski MJ, White C, Golightly MG, Steingart R, Otto RN, Podgurski AE, Johnson ML, Glynn P, Smith DE (1989) Natural killer lymphocyte blast crisis of chronic myelogenous leukemia. Am J Hematol 32:279-286
6. Cho EK, Heo DS, Seol JG, Seo EJ, Chi HS, Kim ES, Lee YY, Kim BK, Kim NK (2000) Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia. Br J Haematol 111:216-222
7. Nakajima H, Zhao R, Lund TC, Ward J, Dolan M, Hirsch B, Miller JS (2002) The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients. J Immunol 168:643-650
8. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD (1994) HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French - American - British acute myeloid leukemia-M3. Blood 84:244-255
9. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S (1997) CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity. Blood 90:2417-2428
10. Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y, Hirai H (1996) Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia 10:788-794
11. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H (1994) Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504-510
12. Murase T, Suzuki R, Tashiro K, Morishima Y, Nakamura S (1999) Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor. Int J Hematol 69:89-91
13. Kahl C, Pelz AF, Bartsch R, Jentsch-Ullrich K, Bruckner R, Fostitsch HP, Franke A (2001) Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes. Ann Hematol 80:58-61
14. Zeppa P, Marino G, Picardi M, Luciano L, Vetrani A, Palombini L (2002) Expression of NK-associated antigens in extramedullary lymph nodal blast crisis of chronic myeloid leukemia on fine-needle cytology. Diagn Cytopathol 27:158-160
15. Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84:1243-1248
16. Storlazzi CT, Anelli L, Albano F, Zagaria A, Ventura M, Rocchi M, Panagopoulos I, Pannunzio A, Ottaviani E, Liso V, Specchia G (2004) A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. Ann Hematol 83:78-83
17. Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH (1994) Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 180:569-576
18. Shibuya A, Nagayoshi K, Nakamura K, Nakauchi H (1995) Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood 85:3538-3546
19. Johansson B, Fioretos T, Mitelman F(2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76-94
20. Cuenco GM, Ren R (2001) Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene 20:8236-8248
21. Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H (1995) Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol Cell Biol 15:2383-2392
22. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette RL, Druker BJ (2002) Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 99:3530-3539
23. Sureda A, Carrasco M, de Miguel M, Martinez JA, Conde E, Sanz MA, Diaz-Mediavilla J, Sierra J (2003) Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia. Haematologica 88:1213-1220